Watch These Today: Ford Motor Company (NYSE:F), Tesla Motors Inc (NASDAQ:TSLA), Merck & Co. Inc. (NYSE:MRK), Galena Biopharma Inc (NASDAQ:GALE), Antero Resources Corporation (NYSE:AR)

Ford Motor Company (NYSE:F) ended the last trading day at $12.26. Company weekly volatility is calculated as 3.36% and price to cash ratio as 3.31. Ford Motor Company (NYSE:F) showed a weekly performance of 2.59%.

On 26 January, Tesla Motors Inc (NASDAQ:TSLA) shares moved down -1.44% and was closed at $193.56. TSLA EPS growth in last 5 year was 21.50%. Tesla Motors Inc (NASDAQ:TSLA) year to date (YTD) performance is -19.35%.
 
Ford Motor Company (NYSE:F) said that, it is pulling out of Japan and Indonesia, saying that market conditions in each country have made it difficult to grow sales or make sustained profits.

Merck & Co. Inc. (NYSE:MRK) shares increased 1.04% in last trading session and ended the day at $51.45. MRK Gross Margin is 63.70% and its has a return on assets of 10.50%. Merck & Co. Inc. (NYSE:MRK) quarterly performance is -1.86%.
 
Tesla Motors Inc (NASDAQ:TSLA) said that, CEO of electric-car company Tesla Motors and co-founder of aerospace manufacturer SpaceX, Paypal and Zip2 is to speak at a technology startup forum in Hong Kong in two week’s time.

Galena Biopharma Inc (NASDAQ:GALE) caters to the Healthcare space. Its weekly performance is 7.50%. On the last day of trading company shares ended up at $0.77. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average (SMA50) is -20.16%.
 
Merck & Co. Inc. (NYSE:MRK) said that, its chief executive of German pharmaceuticals giant Merck KGaA ruled out any major mergers & acquisitions this year, saying much of the reshaping of the firm’s portfolio has been completed.

Antero Resources Corporation (NYSE:AR) caters to the Basic Materials space. It has a net profit margin of 31.00% and weekly performance is 19.48%. On the last day of trading company shares ended up at $24.96. Antero Resources Corporation (NYSE:AR) distance from 50-day simple moving average (SMA50) is 16.83%.
Galena Biopharma Inc (NASDAQ:GALE) presented data from an observational study in gastric cancer patients at the American Society of Clinical Oncology (ASCO) 2016 Gastrointestinal Cancers Symposium in San Francisco, CA.  The study was conducted by Galena’s partner, Dr. Reddy’s Laboratories Ltd, under the license agreement for NeuVax™ (nelipepimut-S) which includes the commercialization rights in India. As part of the license agreement, Dr. Reddy’s will conduct a Phase 2 clinical trial of NeuVax in gastric cancer patients in India.

On 13 January, Antero Resources Corporation (NYSE:AR) announced its fourth quarter 2015 operations update. Average net daily gas equivalent production was 1,497 MMcfe/d, an 18% increase over the prior year quarter and a 1% decrease sequentially